1. Home
  2. CVRX vs III Comparison

CVRX vs III Comparison

Compare CVRX & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • III
  • Stock Information
  • Founded
  • CVRX 2000
  • III 2006
  • Country
  • CVRX United States
  • III United States
  • Employees
  • CVRX N/A
  • III N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • III Professional Services
  • Sector
  • CVRX Health Care
  • III Consumer Discretionary
  • Exchange
  • CVRX Nasdaq
  • III Nasdaq
  • Market Cap
  • CVRX 189.0M
  • III 207.8M
  • IPO Year
  • CVRX 2021
  • III 2007
  • Fundamental
  • Price
  • CVRX $7.80
  • III $5.03
  • Analyst Decision
  • CVRX Buy
  • III Buy
  • Analyst Count
  • CVRX 7
  • III 1
  • Target Price
  • CVRX $14.00
  • III $5.50
  • AVG Volume (30 Days)
  • CVRX 309.8K
  • III 280.8K
  • Earning Date
  • CVRX 08-04-2025
  • III 08-06-2025
  • Dividend Yield
  • CVRX N/A
  • III 3.74%
  • EPS Growth
  • CVRX N/A
  • III N/A
  • EPS
  • CVRX N/A
  • III 0.16
  • Revenue
  • CVRX $54,652,000.00
  • III $240,201,000.00
  • Revenue This Year
  • CVRX $11.32
  • III N/A
  • Revenue Next Year
  • CVRX $18.58
  • III $5.08
  • P/E Ratio
  • CVRX N/A
  • III $32.05
  • Revenue Growth
  • CVRX 23.11
  • III N/A
  • 52 Week Low
  • CVRX $4.30
  • III $2.95
  • 52 Week High
  • CVRX $18.55
  • III $5.28
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 56.11
  • III 62.80
  • Support Level
  • CVRX $7.08
  • III $4.77
  • Resistance Level
  • CVRX $7.79
  • III $5.04
  • Average True Range (ATR)
  • CVRX 0.56
  • III 0.21
  • MACD
  • CVRX -0.00
  • III 0.05
  • Stochastic Oscillator
  • CVRX 96.49
  • III 91.96

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About III Information Services Group Inc.

Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.

Share on Social Networks: